Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report

Atag E., Semiz H. S., KAZAZ S. N., Tuna E. B., Ozdogan Ö., Bozkurt O., ...More

UROLOGY JOURNAL, vol.14, no.1, pp.2985-2988, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 1
  • Publication Date: 2017
  • Journal Name: UROLOGY JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2985-2988
  • Keywords: cabazitaxel, penile metastasis, prostate cancer, CARCINOMA, ADENOCARCINOMA, TUMORS
  • Dokuz Eylül University Affiliated: Yes


Penile metastases are extremely rare events and generally occurs at a late stage of primary disease. They mostly originate from prostate and bladder in the genitourinary tract. Penile metastases have a dismal prognosis and very low survival rates. We report a case of penile metastasis in 70-year-old geriatric male patient with prostatic adenocarcinoma who was treated with cabazitaxel chemotherapy beyond 20 cycles with a good response and acceptable minimal toxicity.